购物车
- 全部删除
- 您的购物车当前为空
Ligandrol 是一种新型的非甾体口服 SARM,以高亲和力(Ki:1 nM)和选择性与雄激素受体结合。
为众多的药物研发团队赋能,
让新药发现更简单!
Ligandrol 是一种新型的非甾体口服 SARM,以高亲和力(Ki:1 nM)和选择性与雄激素受体结合。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 153 | 期货 | |
10 mg | ¥ 248 | 期货 | |
25 mg | ¥ 413 | 期货 | |
50 mg | ¥ 592 | 期货 | |
100 mg | ¥ 873 | 期货 | |
200 mg | ¥ 1,290 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 253 | 期货 |
产品描述 | Ligandrol is a novel nonsteroidal, oral SARM that binds to the androgen receptor with high affinity (Ki: 1 nM) and selectivity. |
靶点活性 | Androgen receptor:Ki: 1 nM |
体外活性 | Ligandrol (LGD-4033), a novel nonsteroidal oral, selective androgen receptor modulator, binds androgen receptor with high affinity and selectivity. |
体内活性 | Ligandrol (LGD-4033) has demonstrated anabolic activity in the muscle, anti-resorptive and anabolic activity in bone, and robust selectivity for muscle versus prostate In animal models. Ligandrol is well tolerated, has a long elimination half-life and dose-proportional accumulation upon multiple dosing. Ligandrol is safe, has favorable pharmacokinetic profile, and increases lean body mass even during this short period without change in prostate-specific antigen. |
别名 | LGD-4033 |
分子量 | 338.25 |
分子式 | C14H12F6N2O |
CAS No. | 1165910-22-4 |
Smiles | C1C[C@@H](N(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)[C@H](C(F)(F)F)O |
密度 | 1.45 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (295.64 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容